Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 476

    1.
    2.

    Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States.

    Camras CB, Sheu WP; United States Latanoprost-Brimonidine Study Group.

    J Glaucoma. 2005 Apr;14(2):161-7.PMID: 15741820 [PubMed - indexed for MEDLINE]Related articles

    3.

    Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.

    Olander K, Zimmerman TJ, Downes N, Schoenfelder J; Xalacom/Latanoprost Study Group.

    Clin Ther. 2004 Oct;26(10):1619-29.PMID: 15598478 [PubMed - indexed for MEDLINE]Related articles

    4.

    A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.

    DuBiner HB, Mroz M, Shapiro AM, Dirks MS; Brimonidine vs. Latanoprost Study Group.

    Clin Ther. 2001 Dec;23(12):1969-83.PMID: 11813932 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intraocular pressure-lowering effects of latanoprost and brimonidine therapy in patients with open-angle glaucoma or ocular hypertension: a randomized observer-masked multicenter study.

    Kampik A, Arias-Puente A, O'Brart DP, Vuori ML; European Latanoprost Study Group.

    J Glaucoma. 2002 Apr;11(2):90-6.PMID: 11912355 [PubMed - indexed for MEDLINE]Related articles

    6.

    Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.

    Simmons ST, Earl ML; Alphagan/Xalatan Study Group.

    Ophthalmology. 2002 Feb;109(2):307-14; discussion 314-5.PMID: 11825814 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.

    Simmons ST, Samuelson TW.

    Clin Ther. 2000 Apr;22(4):388-99.PMID: 10823361 [PubMed - indexed for MEDLINE]Related articles

    8.

    A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.

    Diestelhorst M, Larsson LI; European Latanoprost Fixed Combination Study Group.

    Br J Ophthalmol. 2004 Feb;88(2):199-203.PMID: 14736774 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double-masked, parallel clinical trials.

    Zabriskie N, Netland PA; Brimonidine with Latanoprost Study Groups 1 and 2.

    Adv Ther. 2003 Mar-Apr;20(2):92-100.PMID: 12836809 [PubMed - indexed for MEDLINE]Related articles

    10.

    Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.

    Shin DH, Feldman RM, Sheu WP; Fixed Combination Latanoprost/Timolol Study Group.

    Ophthalmology. 2004 Feb;111(2):276-82.PMID: 15019375 [PubMed - indexed for MEDLINE]Related articles

    11.

    Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.

    Sherwood MB, Craven ER, Chou C, DuBiner HB, Batoosingh AL, Schiffman RM, Whitcup SM.

    Arch Ophthalmol. 2006 Sep;124(9):1230-8.PMID: 16966616 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Latanoprost : an update of its use in glaucoma and ocular hypertension.

    Perry CM, McGavin JK, Culy CR, Ibbotson T.

    Drugs Aging. 2003;20(8):597-630. Review.PMID: 12795627 [PubMed - indexed for MEDLINE]Related articles

    14.

    A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.

    Diestelhorst M, Larsson LI; European-Canadian Latanoprost Fixed Combination Study Group.

    Ophthalmology. 2006 Jan;113(1):70-6. Epub 2005 Nov 2.PMID: 16263174 [PubMed - indexed for MEDLINE]Related articles

    15.

    Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial.

    Higginbotham EJ, Feldman R, Stiles M, Dubiner H; Fixed Combination Investigative Group.

    Arch Ophthalmol. 2002 Jul;120(7):915-22.PMID: 12096962 [PubMed - indexed for MEDLINE]Related articles

    17.

    Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.

    Stewart WC, Stewart JA, Day DG, Sharpe ED, Jenkins JN.

    Eye (Lond). 2004 Oct;18(10):990-5.PMID: 15037890 [PubMed - indexed for MEDLINE]Related articles

    19.

    The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.

    Orzalesi N, Rossetti L, Bottoli A, Fumagalli E, Fogagnolo P.

    Arch Ophthalmol. 2003 Apr;121(4):453-7.PMID: 12695241 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily.

    Stewart WC, Stewart JA, Day D, Sharpe ED.

    Acta Ophthalmol Scand. 2003 Jun;81(3):242-6.PMID: 12780402 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data